Center for Scientific Review; Notice of Closed Meetings, 3563-3564 [2022-01230]
Download as PDF
<![CDATA[
3563
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
Collection Clearance Officer at:
Evonne.Bennett@ihs.gov or 301–443–
4750.
This
previously approved information
collection project was last published in
the Federal Register on September 25,
2018, and allowed 30 days for public
comment. No public comment was
received in response to the notice. This
notice announces our intent to submit
this collection, which expires March 31,
SUPPLEMENTARY INFORMATION:
2022, to OMB for approval of an
extension, and to solicit comments on
specific aspects for the proposed
information collection. Title: Purchased/
Referred Care Proof of Residency. OMB
Control Number: 0917–0040. Need and
Use of Information Collection: The IHS
Purchased/Referred Care Program needs
the information requested on the PRC
Proof of Residency form to verify that
individuals seeking medical services
through a PRC program meet the
residency requirements specific to PRC
Estimated
number of
respondents
Data collection instrument(s)
Responses
per
respondent
under 42 CFR 136.23. Agency Form
Number: IHS 976. Members of Affected
Public: Individuals/Households. Status
of the Proposed Information Collection:
Renewal request. Type of Respondents:
Individuals. The table below provides:
Types of data collection instruments,
Estimated number of respondents,
Number of responses per respondent,
Annual number of responses, Average
burden hour per response, and Total
annual burden hours.
Annual
number of
responses
Average
burden hour
per response *
Total annual
burden hours
Individual Patient Count .......................................................
77,185
1
77,185
3/60
3,859.25
Total ..............................................................................
77,185
1
77,185
3/60
3,859.25
* For ease of understanding, the average burden per response is 3 minutes.
There are no direct costs to
respondents to report.
Requests for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points:
(a) Whether the information collection
activity is necessary to carry out an
agency function;
(b) whether the agency processes the
information collected in a useful and
timely fashion;
(c) the accuracy of the public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information);
(d) whether the methodology and
assumptions used to determine the
estimates are logical;
(e) ways to enhance the quality,
utility, and clarity of the information
being collected; and
(f) ways to minimize the public
burden through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Elizabeth A. Fowler,
Acting Deputy Director, Indian Health
Service.
[FR Doc. 2022–01250 Filed 1–21–22; 8:45 am]
BILLING CODE 4165–16–P
jspears on DSK121TN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
VerDate Sep<11>2014
18:11 Jan 21, 2022
Jkt 256001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: February 17–18, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Greenberg
Shapero, Ph.D., Scientific Review Officer,
Center for Scientific, Review National
Institutes of Health, 6701 Rockledge Drive,
Room 3182, MSC 7848, Bethesda, MD 20892,
(301) 402–4786, shaperobg@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Collaborative Applications: Clinical Studies
of Mental Illness.
Date: February 17, 2022.
Time: 2:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin G. Shapero,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
Bethesda, MD 20892, (301) 402–4786,
shaperobg@mail.nih.gov.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Maximizing Investigators’ Research Award A
Study Section.
Date: February 22–23, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elena Smirnova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187,
MSC 7840, Bethesda, MD 20892, 301–357–
9112, smirnove@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics Study Section.
Date: February 23–25, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Integrative Myocardial Physiology/
Pathophysiology A Study Section.
Date: February 23–24, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abdelouahab Aitouche,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222,
MSC 7814, Bethesda, MD 20892, 301–435–
2365, aitouchea@csr.nih.gov.
E:\FR\FM\24JAN1.SGM
24JAN1
jspears on DSK121TN23PROD with NOTICES1
3564
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Noninvasive Neuromodulation and
Neuroimaging Technologies.
Date: February 23, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pablo M. Blazquez Gamez,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042,
pablo.blazquezgamez@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: February 23–25, 2022.
Time: 12:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030,
Bethesda, MD 20817, (301) 435–4436, tangt@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics: Vision Imaging, Bioengineering and
Low Vision Technology Development.
Date: February 24–25, 2022.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Gillmor, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 240–
762–3076, susan.gillmor@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience.
Date: February 24–25, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jennifer Kielczewski,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, jennifer.kielczewski@
nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Prevention Study Section.
Date: February 28-March 1, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:11 Jan 21, 2022
Jkt 256001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, 301–594–7945,
kotliars@mail.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Mechanisms of Cancer
Therapeutics—2 Study Section.
Date: February 28–March 1, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301) 435–
3504, tothct@csr.nih.gov.
Name of Committee: Oncology 1-Basic
Translational Integrated Review Group;
Molecular Oncogenesis Study Section.
Date: February 28–March 1, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
6701 Rockledge Drive, Bethesda, MD 20892,
301–827–5902, caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Membrane Biochemistry and
Biophysics.
Date: February 28, 2022.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interdisciplinary Molecular Sciences and
Training Member Conflict.
Date: February 28, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8254, john.laity@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
public.csr.nih.gov/StudySections/DBIB/GGG,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 18, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–01230 Filed 1–21–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative
Innovation Awards Review Meeting.
Date: February 23, 2022.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, 301–435–0810,
lourdes.ponce@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3563-3564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01230]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Adult Psychopathology and Disorders of
Aging Study Section.
Date: February 17-18, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Greenberg Shapero, Ph.D., Scientific
Review Officer, Center for Scientific, Review National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7848, Bethesda, MD
20892, (301) 402-4786, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Collaborative Applications: Clinical Studies of Mental
Illness.
Date: February 17, 2022.
Time: 2:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin G. Shapero, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, Bethesda, MD 20892, (301)
402-4786, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Maximizing Investigators' Research Award A Study
Section.
Date: February 22-23, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elena Smirnova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD
20892, 301-357-9112, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics Study Section.
Date: February 23-25, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187, MSC 7804, Bethesda, MD
20892, 301-451-0132, [email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Integrative Myocardial Physiology/
Pathophysiology A Study Section.
Date: February 23-24, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Abdelouahab Aitouche, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD
20892, 301-435-2365, [email protected].
[[Page 3564]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics: Noninvasive Neuromodulation and Neuroimaging
Technologies.
Date: February 23, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pablo M. Blazquez Gamez, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: February 23-25, 2022.
Time: 12:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030, Bethesda, MD 20817, (301)
435-4436, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Topics: Vision Imaging, Bioengineering and Low Vision
Technology Development.
Date: February 24-25, 2022.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, Bethesda, MD 20892, 240-762-3076,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Biophysical, Physiological, Pharmacological and
Bioengineering Neuroscience.
Date: February 24-25, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jennifer Kielczewski, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Prevention Study Section.
Date: February 28-March 1, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
594-7945, [email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Mechanisms of Cancer Therapeutics--2 Study Section.
Date: February 28-March 1, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301) 435-3504, [email protected].
Name of Committee: Oncology 1-Basic Translational Integrated
Review Group; Molecular Oncogenesis Study Section.
Date: February 28-March 1, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892,
301-827-5902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Membrane Biochemistry and Biophysics.
Date: February 28, 2022.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Interdisciplinary Molecular Sciences and Training Member
Conflict.
Date: February 28, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-8254,
[email protected].
Information is also available on the Institute's/Center's home
page: https://public.csr.nih.gov/StudySections/DBIB/GGG, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 18, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01230 Filed 1-21-22; 8:45 am]
BILLING CODE 4140-01-P
